V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20206288 | 20077131 | 1.59 | 82 | Palliative (P) | 2019-09-10 | 2019-09-10 | Irinotecan + Modified De Gramont | N | N | IRINOTECAN + MDG | 100370774 |
| 20206290 | 20077132 | null | null | null | 2018-07-27 | 2018-07-27 | Irinotecan + Modified De Gramont | N | null | IRINOTECAN + MDG | 101851109 |
| 20206291 | 20077133 | 1.74 | 63.1 | Palliative (P) | 2016-11-27 | 2016-11-27 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 100878353 |
| 20206292 | 20077134 | 1.63 | 76.3 | Palliative (P) | 2017-10-27 | 2017-10-31 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 100542788 |
| 20206294 | 20077135 | 1.58 | 63.85 | Palliative (P) | 2018-01-15 | 2018-01-18 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 101286642 |
| 20206296 | 20077136 | 1.73 | 64.9 | Palliative (P) | 2016-10-10 | 2016-10-10 | Irinotecan + Modified De Gramont | N | N | CARBOPLATIN + ETOPOSIDE | 101535534 |
| 20206297 | 20077137 | 1.65 | 48.8 | Adjuvant (A) | 2018-01-12 | 2018-01-14 | Irinotecan + Modified De Gramont | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100981326 |
| 20206300 | 20077138 | 1.81 | 80 | null | null | 2017-09-15 | Irinotecan + Modified De Gramont | N | null | CARBOPLATIN + ETOPOSIDE | 101187278 |
| 20206303 | 20077139 | null | 63.6 | Curative (C) | 2016-05-20 | 2016-05-31 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 100810845 |
| 20206304 | 20077140 | null | null | Palliative (P) | 2016-04-20 | 2016-04-26 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100682880 |
| 20206306 | 20077141 | 1.51 | null | null | 2019-03-11 | 2019-04-02 | IRINOTECAN + MDG | 02 | N | IRINOTECAN + MDG | 100061225 |
| 20206308 | 20077142 | 1.63 | 69.1 | null | 2016-06-27 | 2016-07-08 | FLUOROURACIL + IRINOTECAN | N | null | CARBOPLATIN + ETOPOSIDE | 100676687 |
| 20206310 | 20077143 | 1.62 | 42.6 | null | 2016-11-17 | 2016-11-17 | GEMCITABINE + NAB PACLITAXEL | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100341820 |
| 20206311 | 20077144 | 1.68 | 85.4 | Curative (C) | 2020-03-29 | 2020-04-01 | GEMCITABINE + NAB PACLITAXEL | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100199840 |
| 20206313 | 20077145 | 1.8 | 76.6 | Palliative (P) | 2019-08-20 | 2019-08-24 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100503068 |
| 20206314 | 20077146 | 1.61 | 84.2 | Palliative (P) | 2019-09-26 | 2019-10-03 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100432419 |
| 20206315 | 20077147 | 1.86 | 62.8 | Palliative (P) | 2016-12-21 | 2016-12-31 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 100830256 |
| 20206319 | 20077148 | 1.76 | 71.7 | Not known (9) | 2019-06-15 | 2019-07-05 | CARBOPLATIN + ETOPOSIDE | 02 | null | CARBOPLATIN + ETOPOSIDE | 101310959 |
| 20206320 | 20077149 | 1.52 | 50.4 | Palliative (P) | 2017-02-17 | 2017-03-01 | GEMCITABINE + Paclitaxel Albumin | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101498319 |
| 20206321 | 20077150 | 1.58 | 43.7 | null | 2018-06-23 | 2018-06-27 | Irinotecan + Modified De Gramont | 02 | null | IRINOTECAN + MDG | 100887934 |
| 20206323 | 20077151 | 1.78 | 104 | null | 2016-07-29 | 2016-08-06 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | Y | GEMCITABINE + NAB-PACLITAXEL | 100606891 |
| 20206324 | 20077152 | 1.7 | 67.05 | Neo-adjuvant (N) | 2016-01-04 | 2016-01-16 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 100468197 |
| 20206329 | 20077153 | 1.81 | 61.8 | null | 2019-10-13 | 2019-10-14 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 101621437 |
| 20206330 | 20077154 | 1.59 | 52.95 | Palliative (P) | 2019-06-09 | 2019-06-25 | Cisplatin +Fluorouracil (2 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101482835 |
| 20206339 | 20077155 | 0 | 0 | 02 | 2016-02-18 | 2016-03-16 | Doxorubicin chemoembolisation | 99 | Y | DOXORUBICIN EMBOLISATION | 100699264 |
| 20206343 | 20077156 | 1.67 | 67.2 | Neo-adjuvant (N) | 2018-02-22 | 2018-03-20 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101379032 |
| 20206345 | 20077157 | 1.55 | 56.1 | Neo-adjuvant (N) | 2017-05-22 | 2017-05-28 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100719964 |
| 20206347 | 20077158 | 1.7 | 76.6 | Palliative (P) | 2018-11-20 | 2018-11-28 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101478085 |
| 20206348 | 20077159 | null | null | Adjuvant (A) | 2020-08-12 | 2020-09-08 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101657902 |
| 20206349 | 20077160 | 1.63 | 66.4 | Curative (C) | 2016-04-19 | 2016-04-19 | Capecitabine (21days) + Carboplatin | 02 | null | CISPLATIN + FLUOROURACIL | 100871943 |
| 20206350 | 20077161 | 1.62 | 80.7 | Neo-adjuvant (N) | null | 2018-05-14 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100712629 |
| 20206353 | 20077162 | 1.59 | 44 | Neo-adjuvant (N) | 2016-03-21 | 2016-04-16 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101530293 |
| 20206354 | 20077163 | 1.59 | 105.7 | Neo-adjuvant (N) | 2019-10-15 | 2019-11-02 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100940212 |
| 20206358 | 20077164 | 1.91 | 53.9 | Palliative (P) | null | 2016-10-03 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100463654 |
| 20206362 | 20077165 | 1.6 | 67 | Palliative (P) | 2018-01-03 | 2018-01-18 | Cisplatin + Fluorouracil + RT 5day | N | N | CISPLATIN + FLUOROURACIL | 101330849 |
| 20206364 | 20077166 | 1.74 | 77.3 | Palliative (P) | 2019-04-04 | 2019-04-15 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100449152 |
| 20206365 | 20077167 | 1.67 | 69.5 | 03 | 2018-09-30 | 2018-10-21 | Capecitabine (21days) + Carboplatin | N | N | CISPLATIN + FLUOROURACIL | 101545216 |
| 20206366 | 20077168 | 1.55 | 73.8 | null | 2017-08-06 | 2017-08-20 | CAPECITABINE + CARBOPLATIN | 02 | null | CISPLATIN + FLUOROURACIL | 101820613 |
| 20206367 | 20077169 | 1.64 | 67.6 | 03 | 2019-02-01 | 2019-02-12 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 101471110 |
| 20206368 | 20077170 | 1.8 | 132 | Neo-adjuvant (N) | 2018-05-25 | 2018-06-02 | CISPLATIN + FLUOROURACIL + RT | 02 | null | CISPLATIN + FLUOROURACIL | 100957325 |
| 20206369 | 20077171 | 0 | 0 | Palliative (P) | 2020-10-02 | 2020-10-10 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100663405 |
| 20206370 | 20077172 | 1.76 | 72.4 | Neo-adjuvant (N) | 2019-12-14 | 2019-12-22 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100705067 |
| 20206372 | 20077173 | null | 78.7 | null | 2016-07-13 | 2016-08-20 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 100313339 |
| 20206373 | 20077174 | 1.76 | 76.5 | Neo-adjuvant (N) | 2017-03-09 | 2017-03-25 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101786508 |
| 20206374 | 20077175 | 1.61 | 89.5 | Curative (C) | 2018-06-29 | 2018-07-01 | CISPLATIN + FLUOROURACIL + RT | 02 | Y | CISPLATIN + FLUOROURACIL | 100666697 |
| 20206376 | 20077176 | 1.61 | 69.7 | null | 2020-11-08 | 2020-11-25 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100064691 |
| 20206377 | 20077177 | 1.62 | 76.6 | Curative (C) | null | 2016-07-17 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 100777937 |
| 20206379 | 20077178 | 1.72 | 63.5 | null | 2019-04-23 | 2019-05-02 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101702338 |
| 20206383 | 20077179 | 1.58 | 76.9 | Palliative (P) | 2019-04-25 | 2019-05-05 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101131776 |
| 20206385 | 20077180 | null | null | null | 2016-09-21 | 2016-09-27 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 101408590 |